Exciting news! Optime Care, an AscellaHealth company, is expanding its collaboration with Eton Pharmaceuticals to serve as the specialty pharmacy provider for GALZIN® (zinc acetate) —an FDA-approved treatment for Wilson Disease. Through this partnership, we continue our commitment to supporting patients with rare diseases by delivering tailored programs, personalized care, and comprehensive treatment support. Our dedicated teams work to improve access to vital therapies, enhance patient outcomes, and ensure financial assistance is available for those who need it most. Read more in our latest press release: https://lnkd.in/eAmmWvVk #EtonPharmaceuticals #WilsonDisease #SpecialtyPharmacy #PatientSupport #RareDiseases #HealthcareInnovation #GALZIN #Collaboration
